RSS Feeds
Search

Out-licensing

Up-to-date access to technology licensing opportunities worldwide.

Licensing opportunities

Displaying 1..6 of 6 - per page
Order by
Methods and formulations for treating or preventing Vascular Cognitive Impairment (VCI) through mucosal administration of E-selectin, an inducible adhesion molecule on endothelial cells More
A model for studying T cell development, immunological based gastrointestinal disorders More
Compositions and methods for using HMGN and its derivatives as immunoadjuvants in combination, as mixtures or as chemical conjugates, with microbial or tumor antigens More
Synthetic lipid aminocyclitols that promote proliferation of natural killer T-cells and are capable of selectively modulating Th2 or Th1 cytokine release and with longer life than α-galactosylceramide. Potential as vaccine adjutants and as drugs. More
Novel peptides have been developed that are useful to induce Autoimmune Anterior Uveitis (AAU) and to treat symptoms associated with Anterior Uveitis. Additional potential uses for these peptides include identification of specific antigenic or uveitogeni More
Displaying 1..6 of 6 - per page
Order by

Related Reports

Your selection

Therapeutic target
Immune related disorders del
Immunosuppression del

Browse By

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us